According to ResMed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.11724. At the end of 2023 the company had a P/S ratio of 5.62.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.62 | -30.66% |
2022 | 8.10 | -26.75% |
2021 | 11.1 | 11% |
2020 | 9.96 | 23.8% |
2019 | 8.05 | 21.08% |
2018 | 6.65 | 21.44% |
2017 | 5.47 | 23.16% |
2016 | 4.44 | 2.97% |
2015 | 4.32 | -11.37% |
2014 | 4.87 | 12.5% |
2013 | 4.33 | 4.37% |
2012 | 4.15 | 44.59% |
2011 | 2.87 | -37.51% |
2010 | 4.59 | 16.99% |
2009 | 3.92 | 22.79% |
2008 | 3.20 | -40.23% |
2007 | 5.35 | -4.35% |
2006 | 5.59 | 4.11% |
2005 | 5.37 | 15.69% |
2004 | 4.64 | 1.48% |
2003 | 4.57 | 5.52% |
2002 | 4.33 | -54.02% |
2001 | 9.42 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Medtronic MDT | 3.28 | -53.97% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | 5.11 | -28.22% | ๐บ๐ธ USA |
Masimo MASI | 3.52 | -50.61% | ๐บ๐ธ USA |
Allied Healthcare Products AHPI | 0.0006 | -99.99% | ๐บ๐ธ USA |
Inogen INGN | 0.5050 | -92.90% | ๐บ๐ธ USA |
Philips PHG | 0.9821 | -86.20% | ๐ณ๐ฑ Netherlands |